Position in CGEN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$560,748
+$200,934 QoQ
Shares Held
262,032
+55.1% QoQ
Ownership
0.277%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 82 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CGEN Over Time
Shares Held
Position Value (USD)
Derivatives in CGEN
reported options exposure · as of Jun 30, 2021CallValue
$1,415,052
CallShares
170,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,596,705,485 across 322 Biotechnology names. CGEN ranks #265 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in CGEN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $560,748 | 262,032 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $359,814 | 168,927 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $207,318 | 141,033 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $704,431 | 395,748 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $575,889 | 394,445 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $549,877 | 359,397 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $366,412 | 202,438 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $87,482 | 52,073 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,044,420 | 404,814 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $551,350 | 278,460 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $338,267 | 363,728 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $55,843 | 79,777 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $19,085 | 26,508 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $470,137 | 712,329 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $687,558 | 371,653 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,023,966 | 318,002 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,687,917 | 392,539 | Shares | Sole | 2022-02-14 | |
| 2021-06-30 | $1,415,052 | 170,900 | Call | Sole | 2021-08-16 | |
| 2021-03-31 | $5,911,466 | 688,180 | Shares | Sole | 2021-05-17 | |
| 2021-03-31 | $429,500 | 50,000 | Call | Sole | 2021-05-17 | |
| 2020-12-31 | $242,200 | 20,000 | Call | Sole | 2021-02-16 | |
| 2020-12-31 | $6,376,266 | 526,529 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $954,752 | 58,754 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,590,666 | 239,059 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $961,587 | 132,450 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||